Page 36 - Educacional Ponenecias Congreso SEHH-STH 2020
P. 36

sessment of treatment outcomes in light chain amyloidosis. Blood Cancer J. 2020;10:41-9.
❯ Trasplante autólogo de progenitores hematopoyéticos
Sharpley FA, Petrie A, Mahmood S, Sachchithanantham S, Lachmann HJ, Gillmore JD. A 24-year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom. Br J Haematol. 2019 Dec;187(5):642-52.
❯ Tratamiento citostático
Cohen O, Sharpley F, Gillmore JD, Lachmann HJ, Sachchithanantham S, Mah- mood S. Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light-chain amyloidosis. Br J Haematol. 2020 May;189(4):643-9.
Kastritis E, Leleu X, Arnulf B, Zamagni E, Cibeira MT, Kwok F. Bortezomib Melpha- lan and Dexamethasone for light-chain amyloidosis. J Clin Oncol. 2020 Jul 30:JCO2001285.
Manwani R, Mahmood S, Sachchithanantham S, Lachmann HJ, Gillmore JD, Yong K. Carfilzomib is an effective upfront therapy in AL amyloidosis pa- tients with peripheral and autonomic neuropathy. Br J Haematol. 2019 Dec;187(5):638-41.
Milani P, Schönland S, Merlini G, Kimmich C, Foli A, Dittrich T, et al.Treatment of AL amyloidosis with bendamustine: a study of 122 patients. Blood. 2018 Nov 1;132(18):1988-91.
Palladini G,Kastritis E,Maurer MS,Zonder J,Minnema MC,Wechalekar AD.Daratu- mumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA. Blood. 2020 Jul 2;136(1):71-80.
Palladini G, Milani P, Foli A, Basset M, Russo F, Perlini S, Merlini G. A phase 2 trial of pomalidomide and dexamethasone rescue in patients with AL amyloidosis. Blood. 2017;129(15):2120-3.
P a l l a d i n i G , S a c h c h i t h a n a n t h a m S , M i l a n i P, G i l l m o r e J , F o l i A , L a c h m a n n H , e t a l . A E u r o - pean collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis. Blood. 2015 Jul 30;126(5):612-5.
Varga, Lentzsch S, Comenzo RL. Beyond NEOD001 for Systemic Light-chain Amy- loidosis. Blood. 2018 Nov 1;132(18):1992-3.
Wechalekar AD, Whelan C. Encouraging impact of doxycycline on early mortal- ity in cardiac light chain (AL) amyloidosis. Blood Cancer J. 2017;7(3):e546.
 LXII Congreso Nacional de la Sociedad Española de Hematología y Hemoterapia / Ponencias
 36




















































































   34   35   36   37   38